Toshiyuki Itoi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Toshiyuki Itoi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Kenji Hamaoka
Department of Pediatrics Cardiology and Nephrology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
2 shared publicationsTatsujiro Oka
Department of Pediatric Cardiology and Nephrology; Graduate School of Medical Science; Kyoto Prefectural University of Medicine; Kyoto
2 shared publicationsHisashi Satou
Department of Pediatric Cardiology and Nephrology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
1 shared publication- Koji Nomoto
Yakult Central Institute for Microbiological Research, Tokyo, Japan
1 shared publication Masaaki Yamagishi
Department of Pediatrics, Kyoto Prefectural University of Medicine
1 shared publicationMiho Inoue
Division of Intensive Care Medicine, Kyoto Prefectural University of Medicine
1 shared publication
Latest Publications
- 1 January 2018
- Published by Japanese Society of Intensive Care Medicine in Journal of the Japanese Society of Intensive Care Medicine
- Vol. 25 (1) , 41-42
Factors associated with parental consent for pediatric critical care research
- 1 January 2018
- Published by Japanese Society of Intensive Care Medicine in Journal of the Japanese Society of Intensive Care Medicine
- Vol. 25 (1) , 41-42
Factors associated with parental consent for pediatric critical care research
- Open Access
- 5 June 2014
- Published by Springer Nature in Journal of Intensive Care
- Vol. 2 (1) , 36
A pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart disease
Probiotics have currently been widely used in patients undergoing various types of surgeries and improved their clinical outcomes, while data in pediatric cardiac surgery have been lacking. We investigated the safety and effects on the intestinal microbiota of the probiotic Bifidobacterium breve in neonates undergoing surgery for congenital heart disease. This pilot, randomized study was performed in a single-center, university hospital-based pediatric intensive care unit (PICU). Twenty-one neonates undergoing surgery for congenital heart disease at >7 days after birth were randomly allocated to two groups: group A received 3 × 109 colony-forming units (CFU)/day of enteral B. breve strain Yakult (BBG-01), which was started 1 week before and terminated 1 week after surgery (n = 10), and group B did not receive BBG-01 (n = 11). The characteristics of the patients were similar in both groups. The postoperative days until fulfillment of the criteria for discharge from the PICU tended to be fewer in group A (8 [7–8] days) than in group B (9 [8–14] days) (p = 0.10). Likewise, the postoperative days to enteral nutrition or achievement of caloric goal tended to be fewer in group A than in group B. The Bifidobacterium in fecal samples after initiating BBG-01 in group A were significantly higher in number than that in group B. Enterobacteriaceae were significantly fewer in group A than in group B immediately (7.0 [3.9–7.7] vs. 8.5 [8.0–9.1] log10 cells/g) and 1 week (7.7 [7.0–8.1] vs. 9.3 [8.6–9.5] log10 cells/g) after surgery (p < 0.05 for both comparisons). The number of Pseudomonas after 1 week was significantly lower in group A than in group B (p = 0.04). The concentrations of total organic and acetic acids were also significantly higher in group A than in group B. The postoperative course was uncomplicated and all neonates were discharged alive from the PICU. The perioperative administration of a probiotic to neonates undergoing surgery for congenital heart disease was safe and significantly improved their intestinal environment. The positive effects of this treatment on clinically significant outcomes remain to be investigated.
- 5 June 2014
- Published by Springer Nature in Journal of Intensive Care
- Vol. 2 (1) , 36
Open AccessA pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart disease
Probiotics have currently been widely used in patients undergoing various types of surgeries and improved their clinical outcomes, while data in pediatric cardiac surgery have been lacking. We investigated the safety and effects on the intestinal microbiota of the probiotic Bifidobacterium breve in neonates undergoing surgery for congenital heart disease. This pilot, randomized study was performed in a single-center, university hospital-based pediatric intensive care unit (PICU). Twenty-one neonates undergoing surgery for congenital heart disease at >7 days after birth were randomly allocated to two groups: group A received 3 × 109 colony-forming units (CFU)/day of enteral B. breve strain Yakult (BBG-01), which was started 1 week before and terminated 1 week after surgery (n = 10), and group B did not receive BBG-01 (n = 11). The characteristics of the patients were similar in both groups. The postoperative days until fulfillment of the criteria for discharge from the PICU tended to be fewer in group A (8 [7–8] days) than in group B (9 [8–14] days) (p = 0.10). Likewise, the postoperative days to enteral nutrition or achievement of caloric goal tended to be fewer in group A than in group B. The Bifidobacterium in fecal samples after initiating BBG-01 in group A were significantly higher in number than that in group B. Enterobacteriaceae were significantly fewer in group A than in group B immediately (7.0 [3.9–7.7] vs. 8.5 [8.0–9.1] log10 cells/g) and 1 week (7.7 [7.0–8.1] vs. 9.3 [8.6–9.5] log10 cells/g) after surgery (p < 0.05 for both comparisons). The number of Pseudomonas after 1 week was significantly lower in group A than in group B (p = 0.04). The concentrations of total organic and acetic acids were also significantly higher in group A than in group B. The postoperative course was uncomplicated and all neonates were discharged alive from the PICU. The perioperative administration of a probiotic to neonates undergoing surgery for congenital heart disease was safe and significantly improved their intestinal environment. The positive effects of this treatment on clinically significant outcomes remain to be investigated.
- Open Access
- 1 August 2013
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 8 (2) , e93-e94
Stenting as a possible new therapeutic strategy to the obstructed TAPVC
- 1 August 2013
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 8 (2) , e93-e94
Open AccessStenting as a possible new therapeutic strategy to the obstructed TAPVC
- 14 January 2013
- Published by Wiley in Pediatrics International
- Vol. 55 (3) , 272-276
Modulation of C16:0-ceramide in hypertrophied immature hearts by losartan
Background The angiotensin type 2 receptor plays a unique role in growth inhibition in adult myocardium via modulation of ceramide synthesis. Angiotensin type 1 (AT1)‐receptor blockade results in increased angiotensin type 2 receptor activation by angiotensin II, and AT1‐receptor blockers are sometimes prescribed to children for the treatment of cardiac hypertrophy or heart failure. We investigated the changes of ceramide lipid components in hypertrophied immature rabbit hearts after chronic administration of the AT1‐receptor blocker, losartan. Methods One‐week‐old Japanese white rabbits were randomly divided into three groups: sham‐operated control rabbits (Group S), rabbits given distilled water orally for 21 days after aortic constriction (Group H), and rabbits given losartan orally for 21 days after aortic constriction (Group H + L). Results Compared with Group S, the hypertrophy index and left ventricular posterior wall thickness were significantly increased in Group H, but were not different in Group H + L. Total myocardial ceramide levels in Group H and Group H + L were suppressed compared with Group S. The relative fatty acid components of myocardial ceramide in Group H were the same as those in Group S, but Group H + L showed a significant increase in the C16:0 component. Conclusions The total cardiac ceramide levels are depressed by pressure overload of immature rabbit hearts. Losartan reduced the hypertrophy with selective increase of the relative amount of C16:0‐ceramide.
- 14 January 2013
- Published by Wiley in Pediatrics International
- Vol. 55 (3) , 272-276
Modulation of C16:0-ceramide in hypertrophied immature hearts by losartan
Background The angiotensin type 2 receptor plays a unique role in growth inhibition in adult myocardium via modulation of ceramide synthesis. Angiotensin type 1 (AT1)‐receptor blockade results in increased angiotensin type 2 receptor activation by angiotensin II, and AT1‐receptor blockers are sometimes prescribed to children for the treatment of cardiac hypertrophy or heart failure. We investigated the changes of ceramide lipid components in hypertrophied immature rabbit hearts after chronic administration of the AT1‐receptor blocker, losartan. Methods One‐week‐old Japanese white rabbits were randomly divided into three groups: sham‐operated control rabbits (Group S), rabbits given distilled water orally for 21 days after aortic constriction (Group H), and rabbits given losartan orally for 21 days after aortic constriction (Group H + L). Results Compared with Group S, the hypertrophy index and left ventricular posterior wall thickness were significantly increased in Group H, but were not different in Group H + L. Total myocardial ceramide levels in Group H and Group H + L were suppressed compared with Group S. The relative fatty acid components of myocardial ceramide in Group H were the same as those in Group S, but Group H + L showed a significant increase in the C16:0 component. Conclusions The total cardiac ceramide levels are depressed by pressure overload of immature rabbit hearts. Losartan reduced the hypertrophy with selective increase of the relative amount of C16:0‐ceramide.
- 31 October 2007
- Published by Wiley in Pediatrics International
- Vol. 49 (6) , 898-902
Impaired transient elevation of blood hemoglobin in response to acute hypoxia in neonates with asplenia
- 31 October 2007
- Published by Wiley in Pediatrics International
- Vol. 49 (6) , 898-902
Impaired transient elevation of blood hemoglobin in response to acute hypoxia in neonates with asplenia
- Open Access
- 1 January 2007
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 71 (9) , 1492-1495
Coronary Flow Characteristics of Multiple Coronary Artery-Left Ventricular Microfistulae in Young Monozygotic Twins
Coronary artery multiple fistulae of the left ventricular chamber are extremely rare congenital malformations. We report on 13-year-old monozygotic twin brothers who have identical abnormalities of coronary flow reserve as well as the same morphological findings of multiple coronary fistulae of the 3 major coronary arteries to the left ventricular chamber. The left circumflex coronary artery (LCX) had abundant fine communications with the left ventricular chamber and had a higher flow rate than the left anterior-descending coronary artery. The coronary flow reserve obtained from the LCX was lower than the normal value matched for the same age group. The increased shunt flow resulted in enlargement of the left ventricular chamber. This is the first report of coronary flow characteristics in children with multiple coronary fistulae. (Circ J 2007; 71: 1492 - 1495)
- 1 January 2007
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 71 (9) , 1492-1495
Open AccessCoronary Flow Characteristics of Multiple Coronary Artery-Left Ventricular Microfistulae in Young Monozygotic Twins
Coronary artery multiple fistulae of the left ventricular chamber are extremely rare congenital malformations. We report on 13-year-old monozygotic twin brothers who have identical abnormalities of coronary flow reserve as well as the same morphological findings of multiple coronary fistulae of the 3 major coronary arteries to the left ventricular chamber. The left circumflex coronary artery (LCX) had abundant fine communications with the left ventricular chamber and had a higher flow rate than the left anterior-descending coronary artery. The coronary flow reserve obtained from the LCX was lower than the normal value matched for the same age group. The increased shunt flow resulted in enlargement of the left ventricular chamber. This is the first report of coronary flow characteristics in children with multiple coronary fistulae. (Circ J 2007; 71: 1492 - 1495)